Swiss dermatological scientists found the solution for the strong reduction of visible signs of cellulite. Recently patented multifunctional polypeptide Dermatopoietin™ is responsible for skin renewal. After the carrying out of a series of successful efficacy tests, Dermatopoietin™ is used in formulation by anti-aging and anti-cellulite products of the novel brand EVEN™ of Switzerland.
Cellulite (Gynoid lipodystrophy) is characterized by the uneven distribution of subcutaneous adipose tissue in the skin in over 80% of post-adolescent women, giving rise to an irregular, dimpled skin surface of the thighs, abdomen, and/or buttocks. The main causes are fat protrusions into lower dermis as well as a weak and inflexible connective tissue. Cellulite is not a disease, yet many women seek artificial, surgical, and cosmetic remedies for this "unsightly" ill that nature has mercilessly inflicted upon them.
Despite the huge amount of treatment methods on the market the results are rather poor. This can be explained by general misunderstanding and the lack of knowledge about the physiology of cellulite. Quite in contrast to that it was the main concern of Swiss scientists of United Technologies UT AG to start from the very molecular level and trigger skin-own biosynthetic machinery. EVEN™ Body Repair Serum is based on Dermatopoietin™ - a molecule with long pharmaceutical background. It neither delivers any functional components into the skin nor penetrates it. It rather acts by triggering the tissue's own regenerative abilities. As a result the process of cell regeneration starts off on the skin surface and unfolds its action in the deeper layer of skin. In response to Dermatopoietin™ skin cells carry out a complex process of tissue remodeling: controlled by cellular signal cascades it leads to directed reconstruction of skin components like collagen and elastin as well as it triggers cell division and mobilization. Basically it is nothing else than what our skin always does - the self renewal. However with Dermatopoietin™ in happens considerably faster and at the right place.
The know-how of United Technologies UT AG is based on a long-term investigation process in the field of hexa- and polypeptides as well as a number of other patent substances, which are now being used in many different cosmetic and pharmacologic projects worldwide.
Cellulite (Gynoid lipodystrophy) is characterized by the uneven distribution of subcutaneous adipose tissue in the skin in over 80% of post-adolescent women, giving rise to an irregular, dimpled skin surface of the thighs, abdomen, and/or buttocks. The main causes are fat protrusions into lower dermis as well as a weak and inflexible connective tissue. Cellulite is not a disease, yet many women seek artificial, surgical, and cosmetic remedies for this "unsightly" ill that nature has mercilessly inflicted upon them.
Despite the huge amount of treatment methods on the market the results are rather poor. This can be explained by general misunderstanding and the lack of knowledge about the physiology of cellulite. Quite in contrast to that it was the main concern of Swiss scientists of United Technologies UT AG to start from the very molecular level and trigger skin-own biosynthetic machinery. EVEN™ Body Repair Serum is based on Dermatopoietin™ - a molecule with long pharmaceutical background. It neither delivers any functional components into the skin nor penetrates it. It rather acts by triggering the tissue's own regenerative abilities. As a result the process of cell regeneration starts off on the skin surface and unfolds its action in the deeper layer of skin. In response to Dermatopoietin™ skin cells carry out a complex process of tissue remodeling: controlled by cellular signal cascades it leads to directed reconstruction of skin components like collagen and elastin as well as it triggers cell division and mobilization. Basically it is nothing else than what our skin always does - the self renewal. However with Dermatopoietin™ in happens considerably faster and at the right place.
The know-how of United Technologies UT AG is based on a long-term investigation process in the field of hexa- and polypeptides as well as a number of other patent substances, which are now being used in many different cosmetic and pharmacologic projects worldwide.